Sonny Hsiao, Acepodia CEO

Ace­po­di­a's off-the-shelf cell ther­a­pies get an­oth­er $100M for on­col­o­gy tri­als

Cal­i­for­nia and Taipei biotech Ace­po­dia has lined up an­oth­er six-fig­ure fund­ing round to take its off-the-shelf cell ther­a­pies for­ward.

Spun out of No­bel lau­re­ate …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.